Dr Reddy’s Laboratories has also notified its distributors to arrange for return of any recalled product. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.) Dr. Reddy’s Laboratories and Aurobindo Pharma have separately initiated voluntary recalls of a drug each from the U.S. market. Several companies, Sanofi, Dr. Reddy’s Laboratories, and Teva Pharmaceutical, have initiated voluntary recalls of ranitidine products, an anti-acid, due to possible contamination with a nitrosamine impurity, N-nitrosodimethylamine (NDMA). DRL first recalled the drug in June 2015. Atorvastatin is a drug that blocks the production of cholesterol and reduces its level in the blood. Dr Reddy's Recalls over 13,000 Bottles of Hypertension Drug- FDA Submitted by Stephanie Vaccaro on June 19, 2014 - 8:48am India's Dr Reddy's Laboratories Ltd is recalling 13,560 bottles of the high blood pressure drug metoprolol succinate in the United States after it failed a dissolution test, the U.S. Food and Drug Administration said. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries, together referred to as “Dr. Dr Reddy’s recalls anti-seizure drug from the US This is the second recall since the launch of the product in August 2013. Eighteen of the recalled lots were recalled … Dr. Reddy’s Laboratories has recalled one lot of Docetaxel injection vials, a drug used to treat cancer, the US FDA reports.. A total of 1,051 vials of Docetaxel injection 20 mg/mL has been recalled. Wholesalers, distributors, hospitals and pharmacies with an existing inventory of the lot being recalled should stop use and distribution of the product as well as quarantine the product immediately for return or replacement of all recalled products. Dr. Reddy’s – Recall of ranitidine • On October 23, 2019, Dr. Reddy’s announced the voluntary, consumer-level recall of prescription ranitidine due to potential contamination with N-nitrosodimethylamine (NDMA). Dr. Reddy’s … #NationalVolunteerWeek #Thespiriofgiving —30+ days ago. Dr Reddy's Laboratories Limited has recalled cholesterol lowering Atorvastatin Calcium tablets from the US market after noticing certain anomalies in the out of specifications(OOS) investigations. New Delhi, May 10 (PTI) Drug major Dr Reddy's Laboratories is recalling 1,752 bottles of generic heartburn medicine in the US after the American health regulator found quality issues with the product. Dr Reddy's recalls 1,752 bottles of heartburn drug in the US The ongoing Class III recall is on account of "Discolouration" and because the product contains brown pellets, USFDA said. This is a class-3 recall, wh RTTNews . Back in September, The Dr. Reddy’s Over-The-Counter and Specialty Rx team in Princeton used their employer supported community service time to work together to build homes for those in need. Dr.Reddy's Recalls Phytonadione Injectable Emulsion Ampules . Reddy’s”) confirms it h HYDERABAD: Dr Reddy's Laboratories has initiated voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and 40mg from the US market due to quality concerns. Over 236,000 bottles of Dr. Reddy’s Laboratories’ generic version of the popular cholesterol drug Lipitor (atorvastatin) have been recalled in the US and Puerto Rico. 27, 2020, 07:19 AM (RTTNews) - Dr. Reddy's Laboratories Ltd. is recalling four lots of … New Delhi: Drug major Dr Reddy's Laboratories is recalling 1,752 bottles of generic heartburn medicine in the US after the American health regulator found quality issues with the product. Mar. Dr. Reddy's Laboratories Ltd. Date: 10/30/19 On October 23, 2019, the US Food and Drug Administration (FDA) announced that Dr. Reddy’s Laboratories Ltd. was recalling all Ranitidine products with expiration dated September 2019 to June 2021 to the consumer level due to NDMA was found in certain samples of ranitidine. Dive Brief: Indian drugmaker Dr. Reddy's Laboratories is pulling from distribution more than 236,000 bottles of its generic copy of cholesterol drug Lipitor, initiating four voluntary recalls in the U.S. and Puerto Rico. Reddy's Ranitidine Products Recalled For Possible Carcinogen Dr Reddy’s joins move to issue recalls . Dr. Reddy’s said the recalled products were available to consumers at Walgreens, Walmart, Sam’s Club, Kroger, Target, CVS and other retailers. (RTTNews) - Dr. Reddy's Laboratories Ltd. is recalling four lots of Phytonadione Injectable Emulsion Ampules, the U.S. Food and Drug Administration said in a statement. Dr Reddy's shares were trading at Rs 2,552.05 apiece, up 1.12 per cent from their previous close, on BSE. The drug was distributed in the United States, Myanmar and Uzbekistan. Dr Reddy’s Laboratories is recalling 1,752 bottles of generic heartburn medicine in the US after the American health regulator found quality issues with the product. Thank you for supporting the community! Dr Reddy’s Laboratories has initiated voluntary recall of over 80,000 bottles of its drug Atorvastatin Calcium Tablets 10mg, 20mg and 40mg from the US market due to quality concerns. A spokesperson for Sanofi was not immediately available for comment. Recalls Ranitidine Tablets and Capsules. https://www.miamiherald.com/news/local/article236584978.html The company initiated a voluntary recall of 2,280 bottles of Atorvastatin Calcium 40 mg 500 tablets on August 2, according to the US Food and Drug Administration(USFDA). 0 Likes. • Dr. Reddy’s initially announced retail level recalls for prescription and OTC ranitidine in early Vikram Reddy, MD, PhD, is the director of colorectal surgery for Yale Medicine and one of five surgeons who are board-certified specially in colorectal cancer. As per the latest Enforcement Report by the the US Food and Drug Administration (), the Hyderabad-based drug firm is voluntarily recalling 1,752 bottles (1,000 count) of 40 mg Esomeprazole Magnesium … Q3 FY 21 Earnings Call Notification | India Customers Only: For any Dr. Reddy’s product availability related issues, please call us on 1800 425 0014 (Monday to Friday, 8AM to 6PM IST) or emailcustomerservices@drreddys.com Dr Reddy’s announced yesterday that it had initiated a voluntary nationwide recall in the US on October 1, at the retail level for OTC products and at the consumer level for prescription products.. Dr. Reddy's Laboratories Ltd. and its subsidiaries issued a voluntary nationwide recall of its ranitidine medicines used to treat heartburn, the US … Pharma major Dr Reddy’s Laboratories Ltd has initiated recall of 1m752 bottles of generic Esomeprazole Magnesium delayed release capsules in the US.According to …